ZIM
MLNT

Zacks Investment Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Zacks Investment Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-152,787
Closed -$542K – 645
2019
Q1 		$542K Buy
+152,787
New +$542K 0.01% 450